Find therapies in clinical trials near you – page 270

Long-Term Safety Study of GLM101 for Patients with PMM2-CDG

Long-Term Safety Study of GLM101 for Patients with PMM2-CDG

Study Comparing Sirolimus and Methylprednisolone for Patients with Active Thyroid Eye Disease

Study Comparing Sirolimus and Methylprednisolone for Patients with Active Thyroid Eye Disease

Study on Dinutuximab Beta with Chemotherapy for Children and Teens with Newly Diagnosed High-Risk Neuroblastoma

Study on Dinutuximab Beta with Chemotherapy for Children and Teens with Newly Diagnosed High-Risk Neuroblastoma

Study of MDNA11 Alone or with Pembrolizumab for Patients with Advanced Solid Tumors

Study of MDNA11 Alone or with Pembrolizumab for Patients with Advanced Solid Tumors

Study on Datopotamab Deruxtecan and Drug Combination for Patients with Advanced or Metastatic Endometrial, Gastric, Prostate, Ovarian, Colorectal, Urothelial, and Biliary Tract Cancers

Study on the Use of Iron Oxide Nanoparticles in MRI to Detect Lymph Node Metastasis in Patients with Newly Diagnosed Rectal Cancer

Study on the Use of Iron Oxide Nanoparticles in MRI to Detect Lymph Node Metastasis in Patients with Newly Diagnosed Rectal Cancer

Study of AZD9574 and Temozolomide for Patients with Advanced Solid Tumors, Including Breast, Ovarian, Pancreatic, and Prostate Cancers

Study of AZD9574 and Temozolomide for Patients with Advanced Solid Tumors, Including Breast, Ovarian, Pancreatic, and Prostate Cancers

Study of Lenvatinib, Pembrolizumab, and Chemotherapy Combination for Patients with Advanced Esophageal Cancer Previously Treated with PD-1/PD-L1 Therapy

Study of Lenvatinib, Pembrolizumab, and Chemotherapy Combination for Patients with Advanced Esophageal Cancer Previously Treated with PD-1/PD-L1 Therapy

Study on the Effects of Metformin for Improving Muscle Function in Patients with Myotonic Dystrophy Type 1

Study on the Effects of Metformin for Improving Muscle Function in Patients with Myotonic Dystrophy Type 1

Study on the Safety and Effects of Sparsentan for Children with Proteinuric Kidney Diseases

Study on the Safety and Effects of Sparsentan for Children with Proteinuric Kidney Diseases

Study Comparing Two Treatment Strategies for Intermediate-Risk Thyroid Cancer Using Sodium Iodide (131I) in Patients with Post-Surgery Evaluation

Study Comparing Two Treatment Strategies for Intermediate-Risk Thyroid Cancer Using Sodium Iodide (131I) in Patients with Post-Surgery Evaluation

Study on Efgartigimod for Children Aged 2-17 with Generalized Myasthenia Gravis

Study on Efgartigimod for Children Aged 2-17 with Generalized Myasthenia Gravis